Q2 FY2026 · ended Jun 30, 2026 · Revenue $111,822, +0.7% YoY · Filed Aug 14, 2026
Positron Corporation (POSC) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $111,822 and a net loss of $821,400. As of Jun 30, 2026 it held $357,173 in cash and investments and $306,566 in total debt.
Revenue
$111,822
+0.7% vs prior quarter
Net income
$-821,400
+40.4% vs prior quarter
Operating cash flow
$-1.05M
-33.1% vs prior quarter
Free cash flow
$-697,000
+5.9% vs year-ago quarter
EPS
$-0.03
+25.0% vs prior quarter
Dividend per share
None
Shares outstanding
32.85M
+0.0% vs prior quarter
Net cash
$50,607
Q2 FY2026
Operating margin
-718.9%
Q2 FY2026
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- POSC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- TX
- Headquarters
- Westmount, IL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 844985
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q3 FY2015 Sep 30, 2015 |
Q2 FY2015 Jun 30, 2015 |
Q1 FY2015 Mar 31, 2015 |
|---|---|---|---|---|---|
| Revenue | $111,822 | $111,000 | $304,000 | $328,000 | $346,000 |
| Operating income | -$803,914 | -$1.4M | -$170,000 | -$223,000 | -$531,000 |
| Net income | -$821,400 | -$1.4M | -$255,000 | -$375,000 | -$554,000 |
| Diluted EPS | -$0.03 | -$0.04 | — | — | — |
| Operating cash flow | -$1.0M | -$788,710 | — | — | — |
| Total assets | $1.7M | $2.8M | $1.5M | $1.6M | $1.7M |
| Total liabilities | $2.4M | $2.6M | $3.1M | $3.0M | $2.6M |
| Stockholders' equity | -$660,847 | $160,553 | -$1.6M | -$1.3M | -$953,000 |
| Cash and investments | $357,173 | $1.4M | $28,000 | $89,000 | $79,000 |
| Total debt | $306,566 | $323,504 | — | — | $1.0B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 2, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Material agreement
|
Aug 18, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 30, 2025 | Dec 23, 2025 |
All 325 Positron Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.